- Home
- KIDS vs BME Comparison
KIDS vs BME Comparison
Compare KIDS & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KIDS
- BME
- Stock Information
- Founded
- KIDS 2007
- BME 2005
- Country
- KIDS United States
- BME United States
- Employees
- KIDS N/A
- BME N/A
- Industry
- KIDS Medical/Dental Instruments
- BME Trusts Except Educational Religious and Charitable
- Sector
- KIDS Health Care
- BME Finance
- Exchange
- KIDS Nasdaq
- BME Nasdaq
- Market Cap
- KIDS 601.5M
- BME 462.3M
- IPO Year
- KIDS 2017
- BME N/A
- Fundamental
- Price
- KIDS $23.08
- BME $36.54
- Analyst Decision
- KIDS Buy
- BME
- Analyst Count
- KIDS 7
- BME 0
- Target Price
- KIDS $35.71
- BME N/A
- AVG Volume (30 Days)
- KIDS 138.6K
- BME 34.0K
- Earning Date
- KIDS 05-07-2025
- BME 01-01-0001
- Dividend Yield
- KIDS N/A
- BME 6.26%
- EPS Growth
- KIDS N/A
- BME N/A
- EPS
- KIDS N/A
- BME 1.44
- Revenue
- KIDS $212,453,000.00
- BME N/A
- Revenue This Year
- KIDS $18.99
- BME N/A
- Revenue Next Year
- KIDS $17.04
- BME N/A
- P/E Ratio
- KIDS N/A
- BME $28.37
- Revenue Growth
- KIDS 31.28
- BME N/A
- 52 Week Low
- KIDS $20.25
- BME $35.53
- 52 Week High
- KIDS $35.99
- BME $43.20
- Technical
- Relative Strength Index (RSI)
- KIDS 57.86
- BME 45.11
- Support Level
- KIDS $20.69
- BME $36.09
- Resistance Level
- KIDS $21.68
- BME $37.65
- Average True Range (ATR)
- KIDS 1.08
- BME 0.52
- MACD
- KIDS 0.29
- BME 0.11
- Stochastic Oscillator
- KIDS 83.74
- BME 53.16
About KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.